SecBot SecBot
SECBOTREPLAY Home › Report › ARTV

ARTV · RA Capital Management, a 10% owner and director at Artiva…

Artiva Biotherapeutics, Inc. · INSIDER-BUY filed Jun 29, 2026 at 16:20 ET

At the news

BULLISHIMPACT 4/10

INSIDER-BUY filed Jun 29, 2026 at 16:20 ET

RA Capital Management, a 10% owner and director at Artiva Biotherapeutics, purchased ~32.9K shares for $292K over two days.

  • RA Capital Management, a 10% owner/Director, bought 31K shares at $8.88 ($275K) on 6/25 and 1.9K shares at $8.98 ($17K) on 6/26
  • Total insider purchase value: $292K
  • Purchase represents ~0.12% of $242M market cap
  • ARTV has 92% analyst bullish rating (4 Strong Buy, 7 Buy, 1 Hold)

Replay the market's reaction

Step through every 5 minutes around the news, then see how it compares with similar events.

Subscribe for Full Access